XML 48 R34.htm IDEA: XBRL DOCUMENT v3.25.4
Financial Instruments (Tables)
 12 Months Ended
Jan. 31, 2026
Investments, All Other Investments [Abstract]  
Schedule of Financial Instruments by Significant Investment Category
The following tables summarize the Company’s financial instruments by significant investment category as of January 31, 2026 and 2025.
January 31, 2026
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Cash equivalents (1):
Money market funds$1,107 $— $— $1,107 
Commercial paper163 — — 163 
Certificates of deposit54 — — 54 
U.S. government securities96 — — 96 
Other (2)1 — — 1 
Marketable securities:
Short-term
Commercial paper155 — — 155 
Corporate debt securities66 — — 66 
U.S. government securities67 — — 67 
Asset backed securities25 — — 25 
Certificates of deposit16 — — 16 
Other (3)19 — — 19 
Long-term
Corporate debt securities156 1 — 157 
Asset backed securities85 — — 85 
U.S. government securities83 — — 83 
Agency mortgage-backed securities23 — — 23 
Other (4)28 — — 28 
Mutual funds (5) 117 20 — 137 
Total$2,261 $21 $— $2,282 
____________________ 
(1)Included in “Cash and cash equivalents” in the accompanying Consolidated Balance Sheets. These investments are classified as debt securities.
(2)Consists of corporate debt securities.
(3)Consists primarily of agency mortgage-backed securities and agency discount notes.
(4)Consists primarily of agency bonds and sovereign government bonds.
(5)Investments in debt and equity securities that are held in a rabbi trust under non-qualified deferred compensation plans with a corresponding deferred compensation liability. $14 million was classified as current and $123 million was classified as non-current. Included in “Prepaid expenses and other current assets”, “Long-term other assets”, “Accrued compensation”, and “Long-term other liabilities,” in the accompanying Consolidated Balance Sheets.
 
January 31, 2025
Amortized CostGross Unrealized GainsGross Unrealized LossesFair Value
Cash equivalents (1):
Money market funds$618 $— $— $618 
Commercial paper85 — — 85 
Certificates of deposit38 — — 38 
U.S. government securities19 — — 19 
Other (2)4 — — 4 
Marketable securities:
Short-term
Commercial paper96 — — 96 
Corporate debt securities79 — 79 
U.S. government securities74 — — 74 
Asset backed securities19 — — 19 
Other (3)19 — 19 
Long-term
Corporate debt securities96 1 — 97 
Asset backed securities71 — — 71 
Agency mortgage-backed securities40 — — 40 
U.S. government securities52 — (1)51 
Other (4)8 — — 8 
Mutual Funds (5) 106 12 — 118 
Total$1,424 $13 $(1)$1,436 
____________________ 
(1)Included in “Cash and cash equivalents” in the accompanying Consolidated Balance Sheets. These investments are classified as debt securities.
(2)Consists primarily of corporate debt securities.
(3)Consists primarily of agency discount bonds, agency mortgage-backed securities, mortgage-backed securities, and US treasury bonds.
(4)Consists primarily of agency collateralized mortgage obligations and supranational bonds.
(5)Investments in debt and equity securities that are held in a rabbi trust under non-qualified deferred compensation plans with a corresponding deferred compensation liability. $12 million was classified as current and $106 million was classified as non-current. Included in “Prepaid expenses and other current assets”, “Long-term other assets”, “Accrued compensation”, and “Long-term other liabilities,” in the accompanying Consolidated Balance Sheets.
Schedule of Investments Classified by Contractual Maturity Date
The following table summarizes the fair values of investments classified as marketable debt securities by contractual maturity date as of January 31, 2026:
Fair Value
Due within 1 year$314 
Due in 1 year through 5 years384
Due in 5 years through 10 years20
Due after 10 years6
Total
$724 
Schedule of Equity Securities without Readily Determinable Fair Value
Adjustments to the carrying value of our strategic investments in equity securities with no readily determined fair values measured using the measurement alternative are included in Interest and Other Income (Expense), net on the Company’s Consolidated Statements of Operations. These adjustments were as follows:
 Fiscal Year EndedCumulative Amount as of
202620252024January 31, 2026
Upward adjustments$— $— $— $29 
Negative adjustments, including impairments(18)(8)(28)(140)
Net adjustments$(18)$(8)$(28)$(111)
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following tables summarize the Company's financial instruments measured at fair value on a recurring basis by significant investment category as of January 31, 2026 and 2025:
January 31, 2026
Level 1Level 2Level 3Total
Cash equivalents (1):
Money market funds$1,107 $— $— $1,107 
Commercial paper— 163 — 163 
Certificates of deposit— 54 — 54 
U.S. government securities— 96 — 96 
Other (2)— 1 — 1 
Marketable securities:
Short-term
Commercial paper— 155 — 155 
Corporate debt securities— 66 — 66 
U.S. government securities— 67 — 67 
Asset backed securities— 25 — 25 
Certificates of deposit— 16 — 16 
Other (3)— 19 — 19 
Long-term
Corporate debt securities— 157 — 157 
Asset backed securities— 85 — 85 
U.S. government securities— 83 — 83 
Agency bonds— 23 — 23 
Other (4)— 28 — 28 
Long-term other assets:
Mutual funds (5) 137 — — 137 
Derivative assets:
Derivative contract assets (6)— 26 — 26 
Derivative liabilities:
Derivative contract liabilities (7)— (28)— (28)
Total$1,244 $1,036 $— $2,280 
____________________ 
(1)Included in “Cash and cash equivalents” in the accompanying Consolidated Balance Sheets. These investments are classified as debt securities.
(2)Consists of corporate debt securities.
(3)Consists primarily of agency mortgage-backed securities and agency discount notes.
(4)Consists primarily of agency bonds and sovereign government bonds.
(5)Investments in debt and equity securities that are held in a rabbi trust under non-qualified deferred compensation plans with a corresponding deferred compensation liability. Included in “Prepaid expenses and other current assets”, “Long-term other assets”, “Accrued compensation”, and “Long-term other liabilities,” in the accompanying Consolidated Balance Sheets.
(6)Included in “Prepaid expenses and other current assets” or “Long-term other assets” in the accompanying Consolidated Balance Sheets.
(7)Included in “Other accrued liabilities” in the accompanying Consolidated Balance Sheets.
   
January 31, 2025
Level 1Level 2Level 3Total
Cash equivalents (1):
Money market funds$618 $— $— $618 
Commercial paper— 85 — 85
Certificates of deposit— 38 — 38
U.S. government securities— 19 — 19
Other (2)— 4 — 4
Marketable securities:
Short-term
Corporate debt securities— 79 — 79
Commercial paper— 96 — 96
Asset backed securities— 19 — 19
U.S. government securities— 74 — 74
Other (3)— 19 — 19
Long-term
Agency bonds— 40 — 40
Corporate debt securities— 97 — 97
U.S. government securities— 51 — 51
Asset backed securities— 71 — 71
Other (4)— 8 — 8
Long-term other assets:
Mutual Funds (5) 118 — — 118
Derivative assets
Derivative contract assets (6)— 28 — 28
Derivative liabilities
Derivative contract liabilities (7)— (22)— (22)
Total$736 $706 $— $1,442 
____________________ 
(1)Included in “Cash and cash equivalents” in the accompanying Consolidated Balance Sheets. These investments are classified as debt securities.
(2)Consists primarily of corporate debt securities.
(3)Consists primarily of agency discount bonds, agency mortgage-backed securities, mortgage-backed securities, and US treasury bonds.
(4)Consists primarily of agency collateralized mortgage obligations and supranational bonds.
(5)Investments in debt and equity securities that are held in a rabbi trust under non-qualified deferred compensation plans with a corresponding deferred compensation liability. Included in “Prepaid expenses and other current assets”, “Long-term other assets”, “Accrued compensation”, and “Long-term other liabilities,” in the accompanying Consolidated Balance Sheets.
(6)Included in “Prepaid expenses and other current assets” or “Long-term other assets” in the accompanying Consolidated Balance Sheets.
(7)Included in “Other accrued liabilities” in the accompanying Consolidated Balance Sheets.